TrialHaemophilia : the official journal of the World Federation of Hemophilia2019

Perioperative haemostasis with full-length, PEGylated, recombinant factor VIII with extended half-life (rurioctocog alfa pegol) in patients with haemophilia A: Final results of a multicentre, single-arm phase III trial.

Ralph Gruppo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.